Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 65.4 CHF 3.09% Market Closed
Market Cap: 32.7B CHF

Alcon AG
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Alcon AG
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Alcon AG
SIX:ALC
Cash & Cash Equivalents
$1.5B
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Cash & Cash Equivalents
CHf16.4m
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Cash & Cash Equivalents
CHf120.5m
CAGR 3-Years
54%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Cash & Cash Equivalents
CHf36.3m
CAGR 3-Years
28%
CAGR 5-Years
10%
CAGR 10-Years
7%
IVF Hartmann Holding AG
SIX:VBSN
Cash & Cash Equivalents
CHf94.2m
CAGR 3-Years
50%
CAGR 5-Years
25%
CAGR 10-Years
11%
No Stocks Found

Alcon AG
Glance View

Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.

ALC Intrinsic Value
67.41 CHF
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Alcon AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.5B USD

Based on the financial report for Sep 30, 2025, Alcon AG's Cash & Cash Equivalents amounts to 1.5B USD.

What is Alcon AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
1%

Over the last year, the Cash & Cash Equivalents growth was -13%. The average annual Cash & Cash Equivalents growth rates for Alcon AG have been 8% over the past three years , 1% over the past five years .

Back to Top